Brimonidine API manufacturers
compare suppliers & send inquiries for free
Country of origin
Established in: 2005
Portfolio of over 2,000 APIs
Precise quality control
End-to-end global regulatory support
Established in: 1963
World’s 1st exclusive API distributor
Portfolio of 600+ APIs
>250 clients in Europe
Established in: 2011
MOQ: 100 g
Fast Response and Good Communication
Willingness To Start From Small
Flexible Payment Terms
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Looking for Brimonidine 59803-98-4?
- Here you will find a list of producers, manufacturers and traders of Brimonidine. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Brimonidina , Brimonidine , Brimonidinum , Bromoxidine , Brimonidine tartrate
- Cas Number:
- DrugBank number:
- Unique Ingredient Identifier:
You can find a short description about Brimonidine here. Brimonidine is an alpha-adrenergic agonist and 2-imidazoline derivative that was first introduced in 1996. It is considered to be a third generation alpha-2 aadrenergic receptor agonist, since it displays preferential binding at alpha-2 adrenoceptors over alpha-1 receptors. Brimonidine displays a higher selectivity toward the alpha-2 adrenergic receptors than clonidine or apraclonidine, which are also alpha-2 adrenergic agonists.
Alpha-2 adrenergic agonists are members of the ocular hypotensive agent drug class that are used in the chronic treatment of glaucoma. Early treatment and management of glaucoma, which predominantly involves the lowering of intraocular pressure, is critical since glaucoma is considered to be a common cause of blindness worldwide Ophthalmically, brimonidine is used to lower intraocular pressure by reducing aqueous humor production and increasing uveoscleral outflow. Because it is oxidately stable, brimonidine is associated with fewer reports of ocular allergic reactions compared to other alpha-2 adrenergic agonists.
More information such as the structure, indication or toxicity is available on Drugbank, click the ID above.
Brimonidine is a type of Ocular preparations
Ocular preparations are a vital subcategory of pharmaceutical active pharmaceutical ingredients (APIs) used in the formulation of medications and treatments for various eye conditions. These specialized formulations are designed to deliver therapeutic agents directly to the eye, ensuring maximum effectiveness and minimal systemic absorption.
Ocular preparations encompass a wide range of products, including eye drops, ointments, gels, and inserts. These formulations may contain API components such as antibiotics, corticosteroids, antihistamines, lubricants, or mydriatics, depending on the intended therapeutic purpose.
Eye drops are the most common form of ocular preparations, delivering medications in liquid form directly onto the eye surface. They are often used to treat conditions like dry eyes, glaucoma, allergies, and infections. Ointments and gels provide a more viscous consistency, enabling longer contact time with the eye surface and prolonged drug release. Inserts, such as punctal plugs, are used to deliver sustained-release medications.
Ocular preparations are formulated to ensure compatibility with the delicate structures of the eye and to enhance drug penetration. Factors like pH, osmolality, and viscosity are carefully controlled to optimize drug delivery and patient comfort. Additionally, preservatives are often added to prevent microbial contamination and maintain product stability.
In summary, ocular preparations are crucial in treating various eye conditions effectively. They provide targeted drug delivery and ensure optimal therapeutic outcomes with minimal side effects. Whether in the form of eye drops, ointments, gels, or inserts, these pharmaceutical APIs play a vital role in promoting eye health and improving patient well-being.
Brimonidine (Ocular preparations), classified under Ophthalmic Agents
Ophthalmic agents belong to the pharmaceutical API (Active Pharmaceutical Ingredient) category specifically designed for ophthalmic applications. These agents are formulated to treat various eye conditions and disorders. Ophthalmic agents encompass a wide range of medications, including eye drops, ointments, gels, and intraocular implants.
These agents are developed to address specific therapeutic needs related to the eyes, such as reducing intraocular pressure in glaucoma, treating inflammation and infection, relieving dryness and itching, and managing allergies. They may also be used to dilate the pupils during diagnostic procedures or surgeries.
Ophthalmic agents are formulated with precise concentrations of active ingredients to ensure efficacy and safety. Common classes of ophthalmic agents include beta-blockers, prostaglandin analogs, carbonic anhydrase inhibitors, corticosteroids, and antihistamines.
When administering ophthalmic agents, it is crucial to follow proper application techniques to ensure optimal drug delivery and minimize side effects. Eye drops, for example, are typically applied as a gentle instillation into the conjunctival sac, while ointments are applied along the lower eyelid.
These pharmaceutical API ophthalmic agents undergo rigorous quality control and regulatory scrutiny to meet industry standards and ensure patient safety. Manufacturers must comply with Good Manufacturing Practices (GMP) and adhere to stringent quality assurance protocols.
Overall, ophthalmic agents play a vital role in the management and treatment of various eye conditions, providing patients with targeted relief and improving ocular health. It is important to consult with a healthcare professional to determine the appropriate ophthalmic agent for individual needs and to receive proper guidance on usage and potential side effects.
Brimonidine manufacturers | traders | suppliers
We have 17 companies offering Brimonidine from 6 different countries.
Get in contact with the supplier of your choice:
- LGM Pharma from United States
- TIEFENBACHER API + Ingredients from Germany
- Shandong Octagon Chemicals Limited from China
- Unichem Labs. from India
- Changzhou Yabang from China
- Laurus Labs from India
- Symed Labs from India
- Centaur Pharma from India
- FDC from India
- Lupin from India
- Indoco Remedies from India
- Cedarburg Pharma from United States
- Piramal Pharma Solutions from India
- Medichem from Spain
- Micro Labs from India
- Farmak from Czech Republic
- Piramal Healthcare from United Kingdom
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.